300878.SZ
Zhejiang Wecome Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 31.63
−5.07%Margins
Gross margin
33.6%
EBITDA margin
-61.1%
EBIT margin
-84.7%
Net margin
-95.8%
FCF margin
-0.7%
-23.7%
Return on equity
-16.8%
Return on assets
-16.7%
Return on invested capital
0.18x
Asset turnover
CNY 52.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026